Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Jun 8, 2010


David Weitz and John Boyce are among the co-founders of GnuBio, a Harvard University spinout that plans to develop fast and inexpensive microdroplet-based DNA sequencing technology (see article, this issue).

Weitz is a professor of physics and applied physics at Harvard. He is also a co-founder of microdroplet firm RainDance Technologies. Previously, he was a professor of physics at the University of Pennsylvania, and before that, a physicist at Exxon Research and Engineering. He holds a PhD in physics from Harvard.

Boyce is the co-founder of consulting firm Delphi Bio and co-head of business development, sales, and marketing at Affomix. Prior to that, he was head of business development and scientific collaborations at Helicos BioSciences, and before that, he was senior director of commercial development at Parallele Biosciences, now part of Affymetrix, and senior director of sales and marketing at Sequenom.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.